Trial Profile
Efficacy and cytokines of lenalidomide therapy in Japanese patients with relapsed or refractory multiple myeloma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 21 Nov 2012
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Pharmacodynamics; Therapeutic Use
- 20 Nov 2012 Planned end date added as reported by University Hospital Medical Information Network - Japan.
- 08 Feb 2012 New trial record